1. Home
  2. TNC vs CGEM Comparison

TNC vs CGEM Comparison

Compare TNC & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tennant Company

TNC

Tennant Company

HOLD

Current Price

$67.59

Market Cap

1.2B

Sector

Industrials

ML Signal

HOLD

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

HOLD

Current Price

$20.88

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNC
CGEM
Founded
1870
2016
Country
United States
United States
Employees
N/A
109
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.4B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
TNC
CGEM
Price
$67.59
$20.88
Analyst Decision
Buy
Strong Buy
Analyst Count
2
8
Target Price
$79.00
$30.13
AVG Volume (30 Days)
156.6K
750.3K
Earning Date
05-04-2026
05-11-2026
Dividend Yield
1.53%
N/A
EPS Growth
N/A
N/A
EPS
0.45
N/A
Revenue
$1,137,600,000.00
N/A
Revenue This Year
$5.77
N/A
Revenue Next Year
$4.95
$5.20
P/E Ratio
$148.02
N/A
Revenue Growth
N/A
N/A
52 Week Low
$60.18
$5.68
52 Week High
$91.93
$23.19

Technical Indicators

Market Signals
Indicator
TNC
CGEM
Relative Strength Index (RSI) 34.81 49.46
Support Level $64.88 $11.87
Resistance Level $88.96 $23.19
Average True Range (ATR) 2.20 0.96
MACD 0.09 -0.26
Stochastic Oscillator 9.62 51.40

Price Performance

Historical Comparison
TNC
CGEM

About TNC Tennant Company

Tennant Co is engaged in designing, manufacturing and marketing solutions that empower customers to achieve quality cleaning performance, reduce environmental impact and help create a cleaner, safer, healthier world. The Company is committed to creating and commercializing breakthrough, sustainable cleaning innovations to enhance its broad suite of products, including floor maintenance and cleaning equipment, detergent-free and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair service, and asset management solutions. Its products are used in many types of environments, including retail establishments, distribution centers, factories and warehouses, public venues such as arenas and stadiums, office buildings, schools, and more.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a clinical-stage biopharmaceutical company developing therapies for autoimmune diseases and cancer. Its development pipeline comprises the following drug candidates: CLN-978, a CD19xCD3 bispecific T cell engager that is being developed for autoimmune diseases; CLN-049, a FLT3xCD3 bispecific T cell engager being evaluated in an ongoing clinical trial in patients with relapsed/refractory acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS); Velinotamig, a BCMAxCD3 bispecific T cell engager being developed to counter autoimmune diseases; and Zipalertinib, being developed as a treatment for non-small cell lung cancer. Additionally, the company is developing several preclinical programs in autoimmune diseases and oncology.

Share on Social Networks: